CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Seres Therapeutics Inc Company Snapshot
Seres Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Seres Therapeutics Inc with three other companies in this sector in the United States: Kite Pharma Inc (2016 sales of $22.17 million of which 100% was Pharmaceutical), Bioanalytical Systems, Inc. ($20.44 million ), and Senomyx, Inc. ($23.04 million of which 100% was Flavors & Flavor Enhancements).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Seres Therapeutics Inc
  Stock Performance Chart for Seres Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 10.52
(Figures in U.S. Dollars)
1 Week -0.8%   13 Weeks 5.7%  
4 Weeks -4.3%   52 Weeks -3.8%  
 
Seres Therapeutics Inc Key Data:
  Ticker: MCRB Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 21,766,000
(Year Ending Jan 2017).
Employees: 127
  Currency: U.S. Dollars Market Cap: 426,377,062
  Fiscal Yr Ends: December Shares Outstanding: 40,530,139
  Share Type: Ordinary Closely Held Shares: 7,637,592
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.